Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
EB
Evosep Biolabs ApS
aktivCVR 44216701AnpartsselskabBilledskærervej 15, 5230 Odense MForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK -3.7m
Latest period
Source details
Source: dk-regnskabsdata-live-44216701-1793953004478
Document: dk-regnskabsdata-44216701-AZ2wXHbtJ8g52wzXb0ND-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u2
Net result
DKK -4m
Latest period
Source details
Source: dk-regnskabsdata-live-44216701-1793953004478
Document: dk-regnskabsdata-44216701-AZ2wXHbtJ8g52wzXb0ND-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u2
Equity
DKK 701k
Equity ratio: 100%
Source details
Source: dk-regnskabsdata-live-44216701-1793953004478
Document: dk-regnskabsdata-44216701-AZ2wXHbtJ8g52wzXb0ND-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c49
Unit: u2
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | — |
| 2024 | — | DKK -2.9m |
| 2025 | — | DKK -4m |